Spots Global Cancer Trial Database for raloxifene
Every month we try and update this database with for raloxifene cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Raloxifene Use for The Heart | NCT00190593 | Cardiovascular ... Breast Neoplasm... | raloxifene placebo | 55 Years - | Eli Lilly and Company | |
| Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer | NCT01050842 | Prostate Cancer Adenocarcinoma ... Hormone-resista... Stage IV Prosta... | bicalutamide raloxifene quality-of-life... | 18 Years - | Mayo Clinic | |
| Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer | NCT00031811 | Breast Cancer Menopausal Symp... Osteoporosis | raloxifene quality-of-life... | - | OHSU Knight Cancer Institute | |
| Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | NCT00003906 | Breast Cancer | Raloxifene Tamoxifen | 35 Years - | NSABP Foundation Inc | |
| Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer | NCT00004915 | Endometrial Can... | raloxifene | 18 Years - | Northwestern University | |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) | NCT01077817 | Esophageal Canc... Squamous Cell C... Adenocarcinoma | Alendronate Etidronate Ibandronate Risedronate Raloxifene | 55 Years - | Organon and Co | |
| Raloxifene in Preventing Breast Cancer in Premenopausal Women | NCT00019500 | Breast Cancer | raloxifene evaluation of c... | 23 Years - 47 Years | National Cancer Institute (NCI) | |
| Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | NCT00003906 | Breast Cancer | Raloxifene Tamoxifen | 35 Years - | NSABP Foundation Inc | |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) | NCT01077817 | Esophageal Canc... Squamous Cell C... Adenocarcinoma | Alendronate Etidronate Ibandronate Risedronate Raloxifene | 55 Years - | Organon and Co | |
| XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) | NCT04926545 | Malignant Tumor Diarrhea | Xiao Chai Hu Ta... Raloxifene FOLFIRI regimen | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
| Cognition in the Study of Tamoxifen and Raloxifene | NCT00687102 | Cognition Aging | tamoxifen raloxifene | 65 Years - | Wake Forest University Health Sciences | |
| Raloxifene Use for The Heart | NCT00190593 | Cardiovascular ... Breast Neoplasm... | raloxifene placebo | 55 Years - | Eli Lilly and Company | |
| Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome | NCT00427700 | Polycystic Ovar... | clomiphene citr... raloxifene | 18 Years - 38 Years | Hospital de Clinicas de Porto Alegre | |
| Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome | NCT01607320 | Polycystic Ovar... | Raloxifene Clomiphene | 18 Years - 36 Years | Prisma Health-Upstate | |
| Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer | NCT00031811 | Breast Cancer Menopausal Symp... Osteoporosis | raloxifene quality-of-life... | - | OHSU Knight Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
